Cargando…
Chemotherapy-induced weight gain in early-stage breast cancer: a prospective matched cohort study reveals associations with inflammation and gut dysbiosis
BACKGROUND: Early-stage breast cancer patients treated with chemotherapy risk the development of metabolic disease and weight gain, which can result in increased morbidity and reduced quality of life in survivorship. We aimed to analyze changes within the gastrointestinal microbiome of early-stage b...
Autores principales: | Walker, John, Joy, Anil Abraham, Vos, Larissa J., Stenson, Trevor H., Mackey, John R., Jovel, Juan, Kao, Dina, Madsen, Karen L., Wong, Gane Ka-Shu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10173591/ https://www.ncbi.nlm.nih.gov/pubmed/37170273 http://dx.doi.org/10.1186/s12916-023-02751-8 |
Ejemplares similares
-
Characterization of the Gut Microbiome Using 16S or Shotgun Metagenomics
por: Jovel, Juan, et al.
Publicado: (2016) -
Longitudinal Gut Microbiota Dysbiosis Underlies Olanzapine-Induced Weight Gain
por: Qian, Li, et al.
Publicado: (2023) -
Fecal microbiota transplantation reverses antibiotic and chemotherapy-induced gut dysbiosis in mice
por: Le Bastard, Quentin, et al.
Publicado: (2018) -
Is There a Role for Gut Microbiome Dysbiosis in IgA Nephropathy?
por: Monteiro, Renato C., et al.
Publicado: (2022) -
Gastrointestinal Dysbiosis
por: Blumstein, Daniel T., et al.
Publicado: (2014)